The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy
- DOI
- 10.1111/all.14342
- Published
- 2020-05-15
- Container
- Allergy
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/all.14342,
title = {The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy},
author = {Paweł Gajdanowicz and Dries Van Elst and Sylwia Smolińska and Andrzej Eljaszewicz and Liam O'Mahony and Alexander Kettner and Marek Jutel},
year = {2020},
journal = {Allergy},
doi = {10.1111/all.14342},
url = {https://doi.org/10.1111/all.14342}
}RIS
TY - JOUR TI - The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy AU - Paweł Gajdanowicz AU - Dries Van Elst AU - Sylwia Smolińska AU - Andrzej Eljaszewicz AU - Liam O'Mahony AU - Alexander Kettner AU - Marek Jutel PY - 2020 JO - Allergy DO - 10.1111/all.14342 UR - https://doi.org/10.1111/all.14342 ER -
APA
Gajdanowicz, P., Elst, D. V., Smolińska, S., Eljaszewicz, A., O'Mahony, L., Kettner, A., & Jutel, M. (2020). The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy. Allergy. https://doi.org/10.1111/all.14342
Source records
- crossref · retrieved 2026-09-26T17:46:44.785Z